Appointment booking for Dr. Alain Alvarez, MD is currently not available.Dr. Alain Alvarez, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Alain Alvarez, MD (he/him) is a Rheumatologist in Naples, FL with over 16 years of experience. What is your opinion of Dr. Alain Alvarez, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 16 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Alain Alvarez, MD has received over $16,756 which includes payments from the following companies:
$3,497.27 from Janssen Biotech, Inc.
$2,186.40 from AbbVie, Inc.
$1,523.20 from Amgen Inc.
$1,500.22 from Novartis Pharmaceuticals Corporation
$1,074.24 from E.R. Squibb & Sons, L.L.C.
$1,014.27 from Celgene Corporation
$925.16 from UCB, Inc.
$665.57 from Pfizer Inc.
$605.92 from LILLY USA, LLC
$433.92 from Horizon Pharma plc
$383.82 from GlaxoSmithKline, LLC.
$312.88 from Mallinckrodt Enterprises LLC
$309.87 from Genentech USA, Inc.
$287.70 from Genentech, Inc.
$223.12 from Mallinckrodt LLC
$192.89 from GENZYME CORPORATION
$148.66 from Antares Pharma, Inc.
$145.35 from Purdue Pharma L.P.
$133.73 from Mallinckrodt Hospital Products Inc.
$120.39 from GE Healthcare
Payments received by Dr. Alain Alvarez, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!